Research
Hormonal
The intervention group experienced significantly greater improvements in diabetes treatment satisfaction and regimen-related diabetes stress compared to usual care.
Improving treatment satisfaction can enhance adherence to diabetes management strategies.
StrongSupportsmedium confidence
INT had significantly greater improvements in diabetes treatment satisfaction and regimen-related diabetes stress relative to UC.
Why this rating
Based on a randomized controlled trial design.
Source
Virtual Weight Management and Continuous Glucose Monitoring in Patients With Type 2 Diabetes: A Randomized Controlled Trial
Peter T. Katzmarzyk et al. · Obesity · 2026
DOI 10.1002/oby.70204
rct · n=151
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →